VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics
| Image |  |
|---|---|
| Description | scientific article published on 6 February 2018 |
| Author/s |
author: Jeremy M Shefner Jinsy Andrews Merit E Cudkowicz Orla Hardiman |
| Publication date | February 6, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |